➡️ Like The Podcast? Leave A Rating: https://ratethispodcast.com/successstory In this "Lessons" episode, we dive into the challenges and triumphs of building Wondermed, a company focused on ketamine-based treatments. Jose Muñoz Aycart, co-founder and managing director, discusses the unique considerations involved in navigating a new and emerging market within the psychedelic space.Building from Scratch: With no existing models, Wondermed meticulously defined legal aspects, business models, and margins. Navigating complex regulations was crucial, taking two years before launch.Investors Driven by Impact: Wondermed attracted investors passionate about ketamine's benefits and those seeking high-growth market innovation. Their unique model combines technology, service, and product, with personalized treatment creating a patient education marketing opportunity.Staged Investment Journey: Fundraising wasn't a one-time event. Wondermed secured capital in stages as the company transitioned from building to growth phases. Transparency throughout the process, including educating investors about the psychedelic space, built trust and addressed regulatory concerns.➡️ Show Linkshttps://successstorypodcast.com YouTube: https://youtu.be/EnVxZQOH5dM?si=fmTdxv22VGzj0UEu Apple: https://podcasts.apple.com/us/podcast/jose-mu%C3%B1oz-co-founder-of-wondermed-healing-mental/id1484783544?i=1000578188522 Spotify: https://open.spotify.com/episode/3uL4E3G7L2K3dK4L8yPRX3?si=ef7624c978bc4423 ➡️ Watch the Podcast On Youtubehttps://www.youtube.com/c/scottdclary

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.